Complement-mediated regulation of tissue factor activity in endothelium.
about
Mechanisms involved in antibody- and complement-mediated allograft rejectionLoss of ATP diphosphohydrolase activity with endothelial cell activationHeparan Sulfate Proteoglycan Metabolism and the Fate of Grafted TissuesEndothelial tissue factor stimulation by proteinase 3 and elastaseDisordered regulation of coagulation and platelet activation in xenotransplantation.Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells.New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.Blood coagulation, inflammation, and malaria.Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeEculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.Factors in xenograft rejection.Prospects for xenotransplantation.Role of complement in xenotransplantation.Current status of xenotransplantation.Xenotransplantation--2000Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection.Therapeutic strategies for xenograft rejection.Current status of animal-to-human transplantation.Differential regulation of endothelial cell activation by complement and interleukin 1alphaPathways to acute humoral rejection"Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress.The link between major histocompatibility complex antibodies and cell proliferation.Diagnosis and treatment of antibody-mediated kidney allograft rejection.Role of complement and complement regulatory proteins in the complications of diabetesBeyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection.Tissue factor and tissue factor pathway inhibitor.C6 produced by macrophages contributes to cardiac allograft rejection.New concepts of complement in allorecognition and graft rejectionEndothelial cell protection in xenotransplantation: looking after a key player in rejection.Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantationHuman umbilical cord blood cells alter blood and spleen cell populations after stroke.Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases.Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboonsRapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase.The role of antibodies in transplantation.Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2.The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies
P2860
Q24629268-AC4C85A6-E281-454A-9FD8-B203C9846BD5Q24670257-5B60EDA9-60CD-4CCF-8CD9-78B53B2D62C0Q26797410-70DE9F0E-A216-488A-9E3F-DB51CC9EF9F6Q28366001-6BA45131-B1A6-463C-9D17-086B482C7163Q33334538-214BF528-FBEA-4B7D-B50A-5B5B8603DBF9Q33335746-FE8C3062-1C20-4567-8B76-77E5601D0BFEQ33339749-AE9B9610-16AE-4A1B-9F61-591CCD3BF4A7Q33365683-258635C5-3CB3-4553-9F03-C44EA3791163Q33378580-4015AE23-0C54-4453-B533-6887FE38D1CAQ33396792-04F4E508-E8FF-4F87-B553-A9865BB74B0FQ33421669-A668E528-DC90-4788-BA67-A880D32CAFA5Q33692579-8596D989-5354-4264-96C3-B96400C35B73Q33732951-475B2A66-5B1E-4261-B219-099493D426F2Q33811443-57D15BE9-21FE-4F7F-AFD4-018CDB1BD02FQ33811452-7185B041-CB18-46A3-915B-83A7D7698D44Q33893048-9257DBA4-6D35-496B-BFF0-78E322B27D99Q33951623-2E10EF0C-A085-42B2-B05D-1CAAAE9E3BB8Q34556105-E189D36A-169B-4995-BFE1-44A251189EEDQ34665240-CC45A880-4CB9-4E64-AEF6-F983869F6781Q34803633-1A017EAD-4E70-4061-A6DE-DFEA4E5DC524Q35096103-9F7D4A5C-E0A0-424B-9449-C8D9E9045527Q35130262-3110AE5B-FD0D-43A5-9B50-6E859E39C1F9Q35223952-253E5BFD-7D0D-46CF-914B-C199116C17E8Q35554487-4A4EA5F3-DFCB-40C9-AE14-A87F71A85103Q35657115-4C5C394D-D223-4E34-ACAA-0AFD6405251FQ35666593-374610A8-E9E4-4142-8448-D6261FB2B546Q35750758-D0D4C44F-7A85-48E0-BC86-5221088A1807Q35788306-939F3C73-47C1-4FBF-A25C-2EC900329B19Q36274176-18F61142-2D0D-4B28-BD4E-78F8D05BCB31Q36404498-F869F048-AC40-44F6-A464-1C11E0BE8BB8Q36438240-293E91D7-075B-4718-B2A0-7C6524F274C3Q36540712-947CF683-44C7-492B-B3B2-596C911E1C7BQ36573005-43EBBE3D-83CE-444B-B158-563493476593Q36691036-5C3AF5F9-D1D7-4791-9C1F-C8D74F092844Q36709845-A89BD744-E275-427E-A4D2-0EE008733EF4Q37363951-57457D33-9492-4D84-B851-B876F385A75BQ37371806-C3ADD8BB-66F7-4BBB-8090-A86402D591FAQ37381110-4881CA92-216E-428C-B7FB-7F6F1583BEDBQ37441972-22F687FF-448C-4AA2-9AC2-48888BA18C68Q37581827-F22BA955-2CBE-42C7-95ED-C7CAA02F5748
P2860
Complement-mediated regulation of tissue factor activity in endothelium.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Complement-mediated regulation of tissue factor activity in endothelium.
@ast
Complement-mediated regulation of tissue factor activity in endothelium.
@en
type
label
Complement-mediated regulation of tissue factor activity in endothelium.
@ast
Complement-mediated regulation of tissue factor activity in endothelium.
@en
prefLabel
Complement-mediated regulation of tissue factor activity in endothelium.
@ast
Complement-mediated regulation of tissue factor activity in endothelium.
@en
P2093
P2860
P356
P1476
Complement-mediated regulation of tissue factor activity in endothelium.
@en
P2093
P2860
P304
P356
10.1084/JEM.182.6.1807
P407
P577
1995-12-01T00:00:00Z